The Indian Council of Medical Research has issued guidelines warning against the use of antibiotics for conditions such as low-grade fever and viral bronchitis while advising doctors to follow a timeline while prescribing them. Resistance to Imipenem, which is used to treat infections caused by E coli bacteria, increased from 14 per cent in 2016 to 36 per cent in …
A big chunk of patients in India may no longer benefit from carbapenem, a powerful antibiotic administered mainly in ICU settings to treat pneumonia and septicemia, as they have developed antimicrobial resistance to it, an ICMR study has found. The data analysis done between January 1 and December 31, 2021, pointed towards a sustained increase in drug-resistant pathogens, resulting in …
A big chunk of patients in India may no longer benefit from carbapenem, a powerful antibiotic administered mainly in ICU settings for the treatment of pneumonia and septicemia, as they have developed antimicrobial resistance to it, an ICMR study has found. According to the ICMR report, resistance to Imipenem, which is used to treat infections caused by bacteria E coli, …
